237 related articles for article (PubMed ID: 28961971)
1. Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
Waghmare A; Xie H; Kimball L; Yi J; Özkök S; Leisenring W; Cheng GS; Englund JA; Watkins TR; Chien JW; Boeckh M
J Infect Dis; 2017 Dec; 216(10):1235-1244. PubMed ID: 28961971
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
4. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.
Marty FM; Chemaly RF; Mullane KM; Lee DG; Hirsch HH; Small CB; Bergeron A; Shoham S; Ljungman P; Waghmare A; Blanchard E; Kim YJ; McKevitt M; Porter DP; Jordan R; Guo Y; German P; Boeckh M; Watkins TR; Chien JW; Dadwal SS
Clin Infect Dis; 2020 Dec; 71(11):2787-2795. PubMed ID: 31915807
[TBL] [Abstract][Full Text] [Related]
5. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
6. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
Houist AL; Bondeelle L; Salmona M; LeGoff J; de Latour RP; Rivière F; Soler C; Houdouin V; Dalle JH; Robin C; Fourati S; Griscelli F; Coman T; Chevret S; Bergeron A
Bone Marrow Transplant; 2021 Dec; 56(12):3032-3041. PubMed ID: 34548625
[TBL] [Abstract][Full Text] [Related]
8. Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes.
Pilie P; Werbel WA; Riddell J; Shu X; Schaubel D; Gregg KS
Transpl Infect Dis; 2015 Aug; 17(4):551-7. PubMed ID: 26059180
[TBL] [Abstract][Full Text] [Related]
9. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
10. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation.
Peck AJ; Corey L; Boeckh M
Clin Infect Dis; 2004 Sep; 39(5):673-80. PubMed ID: 15356782
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
12. The clinical features of respiratory syncytial virus: lower respiratory tract infection after upper respiratory tract infection due to influenza virus.
Nishimura N; Nishio H; Lee MJ; Uemura K
Pediatr Int; 2005 Aug; 47(4):412-6. PubMed ID: 16091079
[TBL] [Abstract][Full Text] [Related]
13. Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.
Seo S; Campbell AP; Xie H; Chien JW; Leisenring WM; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2013 Apr; 19(4):589-96. PubMed ID: 23298855
[TBL] [Abstract][Full Text] [Related]
14. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR
Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
[TBL] [Abstract][Full Text] [Related]
15. Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients.
Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Milano F; Englund JA; Boeckh M
J Clin Virol; 2022 Jun; 150-151():105152. PubMed ID: 35447514
[TBL] [Abstract][Full Text] [Related]
16. Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.
Casey J; Morris K; Narayana M; Nakagaki M; Kennedy GA
Bone Marrow Transplant; 2013 Nov; 48(12):1558-61. PubMed ID: 23912665
[TBL] [Abstract][Full Text] [Related]
17. Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection.
Waghmare A; Xie H; Kuypers J; Sorror ML; Jerome KR; Englund JA; Boeckh M; Leisenring WM
Biol Blood Marrow Transplant; 2019 May; 25(5):1011-1021. PubMed ID: 30537551
[TBL] [Abstract][Full Text] [Related]
18. Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients.
Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Ueda Oshima M; Carpenter PA; Englund JA; Boeckh M
Bone Marrow Transplant; 2022 Apr; 57(4):649-657. PubMed ID: 35173288
[TBL] [Abstract][Full Text] [Related]
19. Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.
Chatzis O; Darbre S; Pasquier J; Meylan P; Manuel O; Aubert JD; Beck-Popovic M; Masouridi-Levrat S; Ansari M; Kaiser L; Posfay-Barbe KM; Asner SA
BMC Infect Dis; 2018 Mar; 18(1):111. PubMed ID: 29510663
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.
Shah DP; Ghantoji SS; Ariza-Heredia EJ; Shah JN; El Taoum KK; Shah PK; Nesher L; Hosing C; Rondon G; Champlin RE; Chemaly RF
Blood; 2014 May; 123(21):3263-8. PubMed ID: 24700783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
